Hing C. Wong - 20 Feb 2024 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Executive Officer, Director
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact for Hing C. Wong
Issuer symbol
HCWB
Transactions as of
20 Feb 2024
Transactions value $
$1,035,003
Form type
4
Filing time
22 Feb 2024, 14:24:41 UTC
Previous filing
18 Sep 2023
Next filing
09 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCWB Common Stock Award $1.04M +739K +4.83% $1.40 16.1M 20 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended.